Noncoding RNA As Therapeutic Targets for Hepatocellular Carcinoma

Overview

Journal Semin Liver Dis

Publisher Thieme

Specialty Gastroenterology

Date 2015 Jan 31

PMID 25632936

Citations 39

Authors

Joseph George

Tushar Patel

Affiliations

Soon will be listed here.

Abstract

Recent studies have suggested that noncoding RNAs (ncRNAs) contribute to the pathogenesis and progression of hepatocellular carcinoma (HCC). These RNA genes may be involved in various pathobiological processes such as cell proliferation, apoptosis, angiogenesis, invasion, and metastasis. Aberrant expression of ncRNA resulting from deregulated epigenetic, transcriptional, or posttranscriptional activity has been described in several studies. ncRNAs are comprised of a highly diverse group of transcripts that include microRNAs (miRNAs) and long noncoding RNAs (lncRNAs) as well as several other types of RNA genes. Understanding the molecular mechanisms by which ncRNA contribute to hepatocarcinogenesis may enable the design of ncRNA-based therapeutics for HCC. In this review, the authors provide a perspective on therapeutic applications based on the emerging evidence of a contributory role of miRNAs and lncRNAs to the pathogenesis and progression of HCC. In addition, ncRNAs that are deregulated in expression in HCC may have utility as potential prognostic or diagnostic markers.

Citing Articles

LINC01559 promotes lung adenocarcinoma metastasis by disrupting the ubiquitination of vimentin.

Feng H, Xu D, Jiang C, Chen Y, Wang J, Ren Z Biomark Res. 2024; 12(1):19.

PMID: 38311781 PMC: 10840222. DOI: 10.1186/s40364-024-00571-3.

Novel Y RNA-Derived Fragments Can Differentiate Canine Hepatocellular Carcinoma from Hepatocellular Adenoma.

Ushio N, Hasan M, Arif M, Miura N Animals (Basel). 2023; 13(19).

PMID: 37835660 PMC: 10571523. DOI: 10.3390/ani13193054.

Identification of non-coding RNAs and their functional network associated with optic nerve invasion in retinoblastoma.

Sun J, Gan L, Ding J, Ma R, Qian J, Xue K Heliyon. 2023; 9(2):e13813.

PMID: 36852072 PMC: 9958441. DOI: 10.1016/j.heliyon.2023.e13813.

Competing endogenous RNA networks related to prognosis in chronic lymphocytic leukemia: comprehensive analyses and construction of a novel risk score model.

Zhang X, Han Y, Hu X, Wang H, Tian Z, Zhang Y Biomark Res. 2022; 10(1):75.

PMID: 36271413 PMC: 9585723. DOI: 10.1186/s40364-022-00423-y.

Non-coding RNAs Regulate the Pathogenesis of Aortic Dissection.

Hu Y, Cheng X, Wu N, Tao Y, Wang X Front Cardiovasc Med. 2022; 9:890607.

PMID: 35498004 PMC: 9051029. DOI: 10.3389/fcvm.2022.890607.

References

Zhang Y, Takahashi S, Tasaka A, Yoshima T, Ochi H, Chayama K . Involvement of microRNA-224 in cell proliferation, migration, invasion, and anti-apoptosis in hepatocellular carcinoma. J Gastroenterol Hepatol. 2012; 28(3):565-75. DOI: 10.1111/j.1440-1746.2012.07271.x. View

Xu D, He X, Chang Y, Sun S, Xu C, Lin J . Downregulation of MiR-93 expression reduces cell proliferation and clonogenicity of HepG2 cells. Hepatogastroenterology. 2012; 59(120):2367-73. DOI: 10.5754/hge12458. View

Braconi C, Patel T . Non-coding RNAs as therapeutic targets in hepatocellular cancer. Curr Cancer Drug Targets. 2012; 12(9):1073-80. PMC: 3916140. View

Liu Y, Pan S, Liu L, Zhai X, Liu J, Wen J . A genetic variant in long non-coding RNA HULC contributes to risk of HBV-related hepatocellular carcinoma in a Chinese population. PLoS One. 2012; 7(4):e35145. PMC: 3320879. DOI: 10.1371/journal.pone.0035145. View

Xie H, Ma H, Zhou D . Plasma HULC as a promising novel biomarker for the detection of hepatocellular carcinoma. Biomed Res Int. 2013; 2013:136106. PMC: 3674644. DOI: 10.1155/2013/136106. View

Gramantieri L, Ferracin M, Fornari F, Veronese A, Sabbioni S, Liu C . Cyclin G1 is a target of miR-122a, a microRNA frequently down-regulated in human hepatocellular carcinoma. Cancer Res. 2007; 67(13):6092-9. DOI: 10.1158/0008-5472.CAN-06-4607. View

Carninci P, Kasukawa T, Katayama S, Gough J, Frith M, Maeda N . The transcriptional landscape of the mammalian genome. Science. 2005; 309(5740):1559-63. DOI: 10.1126/science.1112014. View

Perkel J . Visiting "noncodarnia". Biotechniques. 2013; 54(6):301, 303-4. DOI: 10.2144/000114037. View

Kim H, Yoon J, Lee H, Cheong J, Cho S, Shin H . MicroRNA-196A-2 polymorphisms and hepatocellular carcinoma in patients with chronic hepatitis B. J Med Virol. 2013; 86(3):446-53. DOI: 10.1002/jmv.23848. View

10.

Tan W, Li Y, Lim S, Tan T . miR-106b-25/miR-17-92 clusters: polycistrons with oncogenic roles in hepatocellular carcinoma. World J Gastroenterol. 2014; 20(20):5962-72. PMC: 4033436. DOI: 10.3748/wjg.v20.i20.5962. View

11.

Zhao J, Wang W, Huang Y, Wu J, Chen M, Cui P . HBx elevates oncoprotein AEG-1 expression to promote cell migration by downregulating miR-375 and miR-136 in malignant hepatocytes. DNA Cell Biol. 2014; 33(10):715-22. DOI: 10.1089/dna.2014.2376. View

12.

Zhou B, Dong L, Jing X, Li J, Yang S, Wang J . Association between miR-146aG>C and miR-196a2C>T polymorphisms and the risk of hepatocellular carcinoma in a Chinese population. Tumour Biol. 2014; 35(8):7775-80. DOI: 10.1007/s13277-014-2020-z. View

13.

Panzitt K, Tschernatsch M, Guelly C, Moustafa T, Stradner M, Strohmaier H . Characterization of HULC, a novel gene with striking up-regulation in hepatocellular carcinoma, as noncoding RNA. Gastroenterology. 2007; 132(1):330-42. DOI: 10.1053/j.gastro.2006.08.026. View

14.

Lai M, Yang Z, Zhou L, Zhu Q, Xie H, Zhang F . Long non-coding RNA MALAT-1 overexpression predicts tumor recurrence of hepatocellular carcinoma after liver transplantation. Med Oncol. 2011; 29(3):1810-6. DOI: 10.1007/s12032-011-0004-z. View

15.

Tsang W, Wong T, Cheung A, Co C, Kwok T . Induction of drug resistance and transformation in human cancer cells by the noncoding RNA CUDR. RNA. 2007; 13(6):890-8. PMC: 1869035. DOI: 10.1261/rna.359007. View

16.

Wei X, Tan C, Tang C, Ren G, Xiang T, Qiu Z . Epigenetic repression of miR-132 expression by the hepatitis B virus x protein in hepatitis B virus-related hepatocellular carcinoma. Cell Signal. 2013; 25(5):1037-43. DOI: 10.1016/j.cellsig.2013.01.019. View

17.

Yang X, Zhang X, Lu X, Jia H, Liang L, Dong Q . MicroRNA-26a suppresses angiogenesis in human hepatocellular carcinoma by targeting hepatocyte growth factor-cMet pathway. Hepatology. 2013; 59(5):1874-85. DOI: 10.1002/hep.26941. View

18.

Xu T, Zhu Y, Xiong Y, Ge Y, Yun J, Zhuang S . MicroRNA-195 suppresses tumorigenicity and regulates G1/S transition of human hepatocellular carcinoma cells. Hepatology. 2009; 50(1):113-21. DOI: 10.1002/hep.22919. View

19.

Li X, Li Z, Song X, Liu C . A variant in microRNA-196a2 is associated with susceptibility to hepatocellular carcinoma in Chinese patients with cirrhosis. Pathology. 2010; 42(7):669-73. DOI: 10.3109/00313025.2010.522175. View

20.

Yuan J, Yang F, Wang F, Ma J, Guo Y, Tao Q . A long noncoding RNA activated by TGF-β promotes the invasion-metastasis cascade in hepatocellular carcinoma. Cancer Cell. 2014; 25(5):666-81. DOI: 10.1016/j.ccr.2014.03.010. View